Intransparent with blackout periods - Anonymous employee BeOne Employee Review

2.0
Feb 17, 2024
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Good product. Good pipeline. Fair base compensation.

Cons

Totally intransparent timing for blackout periods. And very, very long blackout periods. After quarter results are announced, there might be 2-3 weeks to trade, then it is blackout again. Total trading days during the year might be 60 or so. This makes it nearly impossible to sell shares on up days, which invariably occur only during very, very long blackout periods. They keep touting some special plan that you can set up during an open window, but it requires approvals and it also means you cannot maximize because you pick a limit price ahead of time. You have to pre-pick a value at which you want to sell and then hope the price goes that high but not higher, otherwise you have just sold for less than you otherwise could have. It is really annoying because LTIs are marketed during recruitment process and account for a big part of the total comp package.

Explore other reviews about BeOne

5.0
Apr 24, 2026
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Cons

Fast timelines and global expansion may translate into heavy workload and urgency

3.0
Jun 5, 2026
Recommend
CEO approval
Business Outlook

Pros

Good wprk tee lunch and free commute

Cons

Bad work but bad commute to work

See reviews by: Helpful|Rating|Date|All